CClinicalTrials.gg
RecruitingNCT06236399Updated Apr 10, 2024

An EEG Study on the Rhythmic Nature of Perception and Attention

An observational study in Human Brain and Cognition, sponsored by Università Vita-Salute San Raffaele. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-10.

Sponsored by Università Vita-Salute San Raffaele · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Nov 2023; still recruiting 2 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The study involved healthy volunteers (n= 200), in a single center, low-risk intervention protocol of a non-profit nature. The objective of the study is to investigate the neural mechanisms of visual perception and attention, with particular reference to neural oscillations, in the general population through electroencephalogram (EEG) recording and the administration of simple visual tasks on a PC. The study presented is not associated with risks, as EEG is a non-invasive technique for which there are no known contraindications or adverse reactions.

02

Conditions studied

  • Human Brain and Cognition
03

In context

Lead sponsor

Università Vita-Salute San Raffaele is the lead sponsor of 84 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy human volunteers

Inclusion criteria

  • age between 18 and 35 years
  • able/willing to sign the informed consent
  • normal or corrected-to-normal vision and hearing

Exclusion criteria

Exclusion Criteria:

  • history of severe/major neurological or psychiatric conditions
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Electroencephalographic (EEG) oscillatory amplitude

    Amplitude of EEG oscillations in theta, alpha and beta frequency bands

    Time frame: during the intervention

  2. Electroencephalographic (EEG) oscillatory frequency

    Frequency of EEG oscillations in theta, alpha and beta frequency bands

    Time frame: during the intervention

  3. Electroencephalographic (EEG) oscillatory phase coherence

    Phase coherence of EEG oscillations in theta, alpha and beta frequency bands

    Time frame: during the intervention

  4. Autism Quotient (AQ)

    Personality questionnaire measuring subclinical autistic traits. Higher score mean worse outcome. Score range: min.= 0, max.= 50.

    Time frame: during the intervention

  5. Schizotypal Personality Questionnaire (SPQ)

    Personality questionnaire measuring subclinical schizotypal traits. Higher score mean worse outcome. Score range: min.= 0, max.= 74.

    Time frame: during the intervention

07

Study locations

1 of 1 sites recruiting
  • IRCCS Ospedale San Raffaele
    Milan, 20132, Italy
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06236399
Lead sponsor
Università Vita-Salute San Raffaele
Responsible party
Luca Ronconi (Professor, Università Vita-Salute San Raffaele) — Principal investigator
First posted
Feb 1, 2024
Start date
Nov 13, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Apr 10, 2024

Study contacts

Luca Ronconi, PhD
Contact
ronconi.luca@unisr.it
0226434887 ext. +39

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion